The Genetic Mutation Analysis market size is expected to reach $11.47 billion in 2030 at a CAGR of 11.5%, driven by rising prevalence of genetic disorders.
Read MoreThe Genetic Analysis market size is expected to reach $18.75 billion in 2030 at a CAGR of 12.7%, driven by increasing cases of cancer.
Read MoreThe Generic Pharmaceuticals Contract Manufacturing market size is expected to reach $93.56 billion in 2030 at a CAGR of 6.9%, driven by rising demand for biosimilars.
Read MoreThe Generic Pharmaceuticals market size is expected to reach $588.24 billion in 2030 at a CAGR of 6.7%, driven by increasing incidence of chronic diseases.
Read MoreThe Generic Oncology Drugs market size is expected to reach $39.99 billion in 2030 at a CAGR of 7.0%, driven by significant rise in cancer patients.
Read MoreThe Generic Musculoskeletal Disorders Drugs market size is expected to reach $0.09 billion in 2030 at a CAGR of 6.9%, driven by increasing adoption of telemedicine.
Read MoreThe Generic Injectables market size is expected to reach $267.93 billion in 2030 at a CAGR of 13.7%, driven by rising prevalence of cancer and cardiovascular diseases.
Read MoreThe Generic Central Nervous System Drugs market size is expected to reach $132.44 billion in 2030 at a CAGR of 7.2%, driven by rising incidence of mental health disorders.
Read MoreThe General Anesthesia Drugs market size is expected to reach $6.16 billion in 2030 at a CAGR of 3.6%, driven by increasing volume of surgical procedures.
Read MoreThe Gene-Editing Transfection Chemicals market size is expected to reach $1.56 billion in 2030 at a CAGR of 7.7%, driven by accelerated research in gene therapy.
Read More